Patients Stopping Slimming Jabs Put On Pounds Four Times Faster Than Those on Conventional Diets

A recent study suggests that individuals who discontinue blockbuster weight-loss injections like Mounjaro or Wegovy tend to recover shed pounds far faster than those who halt traditional lifestyle regimens.

Findings released in a prominent medical journal demonstrates that while overweight people can lose about a fifth of their total mass while undergoing treatment, the mass comes back at an estimated rate of nearly a kilo each month upon discontinuation.

"Individuals using such medications must be aware of the risk of quick rebound weight gain when the therapy concludes," cautioned lead investigator Dr. Susan Jebb.

This pace of recovery means a return to pre-treatment mass in about a year and a half.

Analyzing Therapies

The analysis, which looked at 37 of trials involving thousands of participants, contrasted the outcomes of these new drugs with older methods.

Scientists point out that people who lose weight through dieting generally see a more gradual weight regain—around 0.1 kg a month—once they finish.

Explaining the Fast Regain

Nutrition scientists propose the mechanism of the injections explains the heightened rebound.

The injections copy a body's own chemical called GLP-1, which helps regulate appetite.

"Artificially providing the hormone levels far above than normal might result in the system to generate a reduced amount of its endogenous GLP-1, and could diminish responsiveness to its effects," explained Dr. Adam Collins, a nutrition specialist.

"Discontinuation of this medication means hunger is no longer kept in check, making excessive eating much more probable."

A Chronic Condition?

Health authorities suggest the jabs for individuals with weight-linked health risks, accompanied by prescribed diet and exercise modifications.

Professionals contend that, given the significant potential of relapse, the therapy might need to be ongoing.

This perspective is reinforced by drug manufacturers, who note that the results "emphasize the long-term nature of obesity," akin to managing conditions like hypertension.

User Testimonies

People who have stopped the jabs explain a intense return of hunger.

"I experienced a switch flipping and I was suddenly ravenous," recalled an individual.

This challenge is compounded if patients have not established lasting dietary or behavioural changes during therapy.

Significant Interest

Figures suggest that millions of people in the UK have used these injections in the past year, with demand continuing to grow.

• Adoption is more common among females than males.
• The 40s and 50s demographic shows the greatest level of interest.
• A large proportion access the medications through private healthcare rather than the NHS.

In conclusion, researchers emphasize that while these medications are effective tools for weight loss, they are not a standalone fix and long-term success likely depends on combined lifestyle changes.